MIR4691: A Potential Drug Target and Biomarker (G100616403)
MIR4691: A Potential Drug Target and Biomarker
MIR4691 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the immune response and has been shown to play a critical role in the regulation of inflammation and autoimmune diseases.
MIR4691 is a small non-coding RNA molecule that is expressed in a variety of tissues and cells, including immune cells, tissues, and organs. It is a key regulator of the immune response and has been shown to play a critical role in the regulation of inflammation and autoimmune diseases.
One of the key functions of MIR4691 is its role in the regulation of T cell development and function. T cells are a crucial part of the immune system and play a critical role in the regulation of inflammation and autoimmune diseases. MIR4691 has been shown to regulate the development and function of T cells, including the development of CD4+ and CD8+ T cells, and the regulation of their cytokine production.
In addition to its role in T cell development, MIR4691 has also been shown to play a critical role in the regulation of inflammation and autoimmune diseases. MIR4691 has been shown to regulate the production and function of immune cells, including the production of dendritic cells, T cells, and B cells, and the regulation of their cytokine production.
MIR4691 has also been shown to play a critical role in the regulation of cancer cell growth and progression. Cancer cells are a major cause of disease and have the ability to evade the immune system's defenses. MIR4691 has been shown to regulate the growth and progression of cancer cells, including the regulation of their angiogenesis, and the inhibition of their immune evasion.
MIR4691 has also been shown to play a critical role in the regulation of inflammation and autoimmune diseases. MIR4691 has been shown to regulate the production and function of immune cells, including the production of dendritic cells, T cells, and B cells, and the regulation of their cytokine production.
In addition to its role in T cell development, MIR4691 has also been shown to play a critical role in the regulation of inflammation and autoimmune diseases. MIR4691 has been shown to regulate the production and function of immune cells, including the production of dendritic cells, T cells, and B cells, and the regulation of their cytokine production.
MIR4691 has also been shown to play a critical role in the regulation of cancer cell growth and progression. Cancer cells are a major cause of disease and have the ability to evade the immune system's defenses. MIR4691 has been shown to regulate the growth and progression of cancer cells, including the regulation of their angiogenesis, and the inhibition of their immune evasion.
MIR4691 has been shown to have a negative impact on cancer cell survival and to be a potential drug target. MIR4691 has been shown to inhibit the migration and invasion of cancer cells, and to inhibit the development of cancer stem cells. MIR4691 has also been shown to regulate the production and function of cancer cells, including the regulation of their angiogenesis, and the inhibition of their immune evasion.
In addition to its potential as a drug target, MIR4691 has also been shown to have a variety of potential biomarker properties. MIR4691 has been shown to be expressed in a variety of tissues and cells, including immune cells, tissues, and organs, and has been shown to be involved in the regulation of a wide range of biological processes, including immune function, inflammation, and cancer.
MIR4691 has also been shown to have a variety of potential applications in cancer treatment. MIR4691 has been shown to be a potential
Protein Name: MicroRNA 4691
The "MIR4691 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4691 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4692 | MIR4693 | MIR4694 | MIR4695 | MIR4697 | MIR4697 host gene (non-protein coding) | MIR4698 | MIR4699 | MIR4700 | MIR4701 | MIR4703 | MIR4704 | MIR4706 | MIR4707 | MIR4708 | MIR4709 | MIR4711 | MIR4712 | MIR4713 | MIR4713HG | MIR4714 | MIR4715 | MIR4716 | MIR4717 | MIR4718 | MIR4720 | MIR4721 | MIR4722 | MIR4723 | MIR4724 | MIR4725 | MIR4726 | MIR4727 | MIR4728 | MIR4729 | MIR4730 | MIR4731 | MIR4732 | MIR4733 | MIR4734 | MIR4735 | MIR4736 | MIR4737 | MIR4738 | MIR4739 | MIR4740 | MIR4741 | MIR4742 | MIR4745 | MIR4746 | MIR4747 | MIR4749 | MIR4750 | MIR4751 | MIR4752 | MIR4753 | MIR4754 | MIR4755 | MIR4756 | MIR4757 | MIR4758 | MIR4759 | MIR4760 | MIR4761 | MIR4762 | MIR4763 | MIR4764 | MIR4765 | MIR4766 | MIR4767 | MIR4768 | MIR4769 | MIR4770 | MIR4771-1 | MIR4771-2 | MIR4772 | MIR4773-1 | MIR4773-2 | MIR4774 | MIR4775 | MIR4776-1 | MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796
